Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

While B-ALL is the most common childhood cancer and one of the most treatable, some patients face grim outcomes after they ...

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of ...

Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...